103 related articles for article (PubMed ID: 12214308)
21. Systems Biology Approaches Reveal Potential Phenotype-Modifier Genes in Neurofibromatosis Type 1.
Woycinck Kowalski T; Brussa Reis L; Finger Andreis T; Ashton-Prolla P; Rosset C
Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32858845
[TBL] [Abstract][Full Text] [Related]
22. Examination of the genetic factors underlying the cognitive variability associated with neurofibromatosis type 1.
Ottenhoff MJ; Rietman AB; Mous SE; Plasschaert E; Gawehns D; Brems H; Oostenbrink R; ; van Minkelen R; Nellist M; Schorry E; Legius E; Moll HA; Elgersma Y
Genet Med; 2020 May; 22(5):889-897. PubMed ID: 32015538
[TBL] [Abstract][Full Text] [Related]
23. Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844-848.
Koczkowska M; Chen Y; Callens T; Gomes A; Sharp A; Johnson S; Hsiao MC; Chen Z; Balasubramanian M; Barnett CP; Becker TA; Ben-Shachar S; Bertola DR; Blakeley JO; Burkitt-Wright EMM; Callaway A; Crenshaw M; Cunha KS; Cunningham M; D'Agostino MD; Dahan K; De Luca A; Destrée A; Dhamija R; Eoli M; Evans DGR; Galvin-Parton P; George-Abraham JK; Gripp KW; Guevara-Campos J; Hanchard NA; Hernández-Chico C; Immken L; Janssens S; Jones KJ; Keena BA; Kochhar A; Liebelt J; Martir-Negron A; Mahoney MJ; Maystadt I; McDougall C; McEntagart M; Mendelsohn N; Miller DT; Mortier G; Morton J; Pappas J; Plotkin SR; Pond D; Rosenbaum K; Rubin K; Russell L; Rutledge LS; Saletti V; Schonberg R; Schreiber A; Seidel M; Siqveland E; Stockton DW; Trevisson E; Ullrich NJ; Upadhyaya M; van Minkelen R; Verhelst H; Wallace MR; Yap YS; Zackai E; Zonana J; Zurcher V; Claes K; Martin Y; Korf BR; Legius E; Messiaen LM
Am J Hum Genet; 2018 Jan; 102(1):69-87. PubMed ID: 29290338
[TBL] [Abstract][Full Text] [Related]
24. NF1 germline mutation differentially dictates optic glioma formation and growth in neurofibromatosis-1.
Toonen JA; Anastasaki C; Smithson LJ; Gianino SM; Li K; Kesterson RA; Gutmann DH
Hum Mol Genet; 2016 May; 25(9):1703-13. PubMed ID: 26908603
[TBL] [Abstract][Full Text] [Related]
25. Coincident liposarcoma, carcinoid and gastrointestinal stromal tumor complicating type 1 neurofibromatosis: Case report and literature review.
James AW; Chang L; Genshaft S; Dry SM
J Orthop; 2015 Oct; 12(Suppl 1):S111-6. PubMed ID: 26719605
[TBL] [Abstract][Full Text] [Related]
26. Optic glioma and precocious puberty in a girl with neurofibromatosis type 1 carrying an R681X mutation of NF1: case report and review of the literature.
Kocova M; Kochova E; Sukarova-Angelovska E
BMC Endocr Disord; 2015 Dec; 15():82. PubMed ID: 26666878
[TBL] [Abstract][Full Text] [Related]
27. The impact of the genetic background in the Noonan syndrome phenotype induced by K-Ras(V14I).
Hernández-Porras I; Jiménez-Catalán B; Schuhmacher AJ; Guerra C
Rare Dis; 2015; 3(1):e1045169. PubMed ID: 26458870
[TBL] [Abstract][Full Text] [Related]
28. Monoallelic loss of the imprinted gene Grb10 promotes tumor formation in irradiated Nf1+/- mice.
Mroue R; Huang B; Braunstein S; Firestone AJ; Nakamura JL
PLoS Genet; 2015 May; 11(5):e1005235. PubMed ID: 26000738
[TBL] [Abstract][Full Text] [Related]
29. Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.
Pemov A; Sung H; Hyland PL; Sloan JL; Ruppert SL; Baldwin AM; Boland JF; Bass SE; Lee HJ; Jones KM; Zhang X; ; Mullikin JC; Widemann BC; Wilson AF; Stewart DR
PLoS Genet; 2014 Oct; 10(10):e1004575. PubMed ID: 25329635
[TBL] [Abstract][Full Text] [Related]
30. Parent-of-origin in individuals with familial neurofibromatosis type 1 and optic pathway gliomas.
Johnson KJ; Fisher MJ; Listernick RL; North KN; Schorry EK; Viskochil D; Weinstein M; Rubin JB; Gutmann DH
Fam Cancer; 2012 Dec; 11(4):653-6. PubMed ID: 22829012
[TBL] [Abstract][Full Text] [Related]
31. Dissecting loss of heterozygosity (LOH) in neurofibromatosis type 1-associated neurofibromas: Importance of copy neutral LOH.
Garcia-Linares C; Fernández-Rodríguez J; Terribas E; Mercadé J; Pros E; Benito L; Benavente Y; Capellà G; Ravella A; Blanco I; Kehrer-Sawatzki H; Lázaro C; Serra E
Hum Mutat; 2011 Jan; 32(1):78-90. PubMed ID: 21031597
[TBL] [Abstract][Full Text] [Related]
32. Monozygotic twins with Neurofibromatosis type 1, concordant phenotype and synchronous development of MPNST and metastasis.
Melean G; Hernández AM; Valero MC; Hernández-Imaz E; Martín Y; Hernández-Chico C
BMC Cancer; 2010 Aug; 10():407. PubMed ID: 20687928
[TBL] [Abstract][Full Text] [Related]
33. Differential MSH2 promoter methylation in blood cells of Neurofibromatosis type 1 (NF1) patients.
Titze S; Peters H; Währisch S; Harder T; Guse K; Buske A; Tinschert S; Harder A
Eur J Hum Genet; 2010 Jan; 18(1):81-7. PubMed ID: 19639020
[TBL] [Abstract][Full Text] [Related]
34. A quantitative assessment of the burden and distribution of Lisch nodules in adults with neurofibromatosis type 1.
Boley S; Sloan JL; Pemov A; Stewart DR
Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5035-43. PubMed ID: 19516012
[TBL] [Abstract][Full Text] [Related]
35. Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1.
Sabbagh A; Pasmant E; Laurendeau I; Parfait B; Barbarot S; Guillot B; Combemale P; Ferkal S; Vidaud M; Aubourg P; Vidaud D; Wolkenstein P;
Hum Mol Genet; 2009 Aug; 18(15):2768-78. PubMed ID: 19417008
[TBL] [Abstract][Full Text] [Related]
36. Neurofibromatosis type 1 in genetic counseling practice: recommendations of the National Society of Genetic Counselors.
Radtke HB; Sebold CD; Allison C; Haidle JL; Schneider G
J Genet Couns; 2007 Aug; 16(4):387-407. PubMed ID: 17636453
[TBL] [Abstract][Full Text] [Related]
37. Mutations in autism susceptibility candidate 2 (AUTS2) in patients with mental retardation.
Kalscheuer VM; FitzPatrick D; Tommerup N; Bugge M; Niebuhr E; Neumann LM; Tzschach A; Shoichet SA; Menzel C; Erdogan F; Arkesteijn G; Ropers HH; Ullmann R
Hum Genet; 2007 May; 121(3-4):501-9. PubMed ID: 17211639
[TBL] [Abstract][Full Text] [Related]
38. An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation.
Upadhyaya M; Huson SM; Davies M; Thomas N; Chuzhanova N; Giovannini S; Evans DG; Howard E; Kerr B; Griffiths S; Consoli C; Side L; Adams D; Pierpont M; Hachen R; Barnicoat A; Li H; Wallace P; Van Biervliet JP; Stevenson D; Viskochil D; Baralle D; Haan E; Riccardi V; Turnpenny P; Lazaro C; Messiaen L
Am J Hum Genet; 2007 Jan; 80(1):140-51. PubMed ID: 17160901
[TBL] [Abstract][Full Text] [Related]
39. The spectrum of NF1 mutations in Korean patients with neurofibromatosis type 1.
Jeong SY; Park SJ; Kim HJ
J Korean Med Sci; 2006 Feb; 21(1):107-12. PubMed ID: 16479075
[TBL] [Abstract][Full Text] [Related]
40. An imprinted locus epistatically influences Nstr1 and Nstr2 to control resistance to nerve sheath tumors in a neurofibromatosis type 1 mouse model.
Reilly KM; Broman KW; Bronson RT; Tsang S; Loisel DA; Christy ES; Sun Z; Diehl J; Munroe DJ; Tuskan RG
Cancer Res; 2006 Jan; 66(1):62-8. PubMed ID: 16397217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
